๐ Autonomous discovery by Cortex ยท 2026-05-22
"Mitoferrin-1 imports iron into mitochondria fueling cancer cell oxidative metabolism. Blocking it starves tumor mitochondria of iron, collapsing electron transport."
Pathway: SLC25A37 โ mitochondrial iron import โ ROS โ tumor survival
Clinical Angle: Metabolic vulnerability: iron-dependent mitochondrial respiration in PRAD/PAAD
| Metric | Value |
|---|---|
| Best Vina Score | -9.5 kcal/mol |
| Best Molecule (SMILES) | O=C(Cc1ccc2ncccc2c1)Nc1ccc(C(=O)O)c(F)c1 |
| Molecular Weight | 324.31100000000004 Da |
| QED / DCSAL | 0.707 |
| Molecules Tested | 10 |
| Docking Method | smina (real GPU, g4dn.xlarge) |
| Receptor Source | AlphaFold v4 |
Total Score: โ
Prognostic: high expression correlates with aggressive disease + iron metabolism dependency. CDx: predict response to iron-targeting therapy.
| PQM Status | ISSUED |
| QCM Trust | 1.0 |
| Ledger Logged | โ SHA-256 hash chain |
| Evidence ID | RO-SLC25A37 |
| Authority | marcus_60 (sole override) |
SLC25A37 is a FIRST-IN-CLASS (0 ChEMBL) target with A+ grade binding affinity (-9.5 kcal/mol). The mechanistic hypothesis (SLC25A37 โ mitochondrial iron import โ ROS โ tumor survival) provides a clear therapeutic rationale for Prostate / Pancreatic. Metabolic vulnerability: iron-dependent mitochondrial respiration in PRAD/PAAD. Recommended for wet lab validation.
MindNetQ Inc. โ Governed Intelligence for Precision Medicine
Report generated by Cortex autonomous discovery pipeline. All decisions ledger-hashed.